statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zevra Therapeutics, Inc. - ZVRA

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - HC Wainwright cut their FY2025 earnings per share estimates for shares of Zevra Therapeutics in a report issued on Wednesday, April 3rd. HC...

HC Wainwright Equities Analysts Lower Earnings Estimates for Zevra Therapeutics, Inc. (NASDAQ:ZVRA)

Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) - Investment analysts at Roth Capital cut their Q1 2024 earnings per share (EPS) estimates for shares of Zevra Therapeutics in a research note...

Roth Capital Equities Analysts Cut Earnings Estimates for Zevra Therapeutics, Inc. (NASDAQ:ZVRA)

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Zevra Therapeutics, Inc...

ZEVRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Zevra Therapeutics, Inc. on Behalf of Zevra Stockholders and Encourages Investors to Contact the Firm

NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zevra Therapeutics, Inc. ( Zevra or the Company ) (NASDAQ: ZVRA). The...

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zevra Therapeutics, Inc. (ZVRA)

ATLANTA, April 02, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Zevra Therapeutics, Inc. ( Zevra or the Company ) (NASDAQ: ZVRA) complied with federal securities laws...

Investigation Into Zevra Therapeutics, Inc. (ZVRA) Announced by Holzer & Holzer, LLC

This is a signal that ZVRA's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Zevra Therapeutics (ZVRA, $5.16) RSI Indicator left the oversold zone on April 01, 2024

Zevra Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Watchers	22,301
52-Wk Low	$3.89
52-Wk High	$7.28

Volume	309,892.00
52-Wk High	$7.28
52-Wk Low	$3.89

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.47	--	--	N/A
Q4'23	-$0.27	-$0.51	-90.06%	MISSED
Q3'23	-$0.30	-$0.40	-34.45%	MISSED
Q2'23	-$0.31	-$0.15	51.61%	BEAT
Q1'23	-$0.23	-$0.34	-46.24%	MISSED

ZVRA Zevra Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals